Part of a year-long series, longtime cannabis law reform advocate and historian Allen St. Pierre examines monthly for Cannabis Business Executive the last fifty years of cannabis prohibition and the public advocacy efforts in America to bring about the ongoing and inescapable socio-political changes underway first at the state, and soon, federal level regarding cannabis policy. […]
NIDA
DEA Mis-scheduling of Cannabis to Keep the Status Quo Ante
Bitter sweetly, the Drug Enforcement Administration (DEA) has affirmed the woeful mis-scheduling of cannabis as a Schedule I drug after sitting on a number of multi-year old petitions (and decades of formal administrative legal challenges). Despite the existing Compassionate Investigational New Drug Program at the National Institute on Drug Abuse (NIDA) that has supplied cannabis as […]
